Skip to main content
Top
Published in: Inflammation 4/2017

01-08-2017 | ORIGINAL ARTICLE

A Critical Role for IL-21 Receptor Signaling in the Coxsackievirus B3-Induced Myocarditis

Authors: Fan Yang, Xiao-mou Wei, Wen-wu Liang, Wen-hong Mo, Bao-ping Tan, Hong Wang

Published in: Inflammation | Issue 4/2017

Login to get access

Abstract

To determine whether IL-21 receptor signaling plays a significant role in promoting Tfh cell-mediated cardiac injury in viral myocarditis (VMC), we compared IL-21R-deficient mice for some parameters of VMC. Balb/c and IL-21R−/− mice were infected with CVB3. Frequencies of splenic Tfh cells were determined by flow cytometric analysis, and productions of anti-adenine nucleotide translocator (ANT) autoantibodies were detected by enzyme-linked immunosorbent assay. To determine the effects of IL-21R signal on the proliferation of B cells, lymphocytes from spleens of the IL-21R−/− and Balb/c mice infected by CVB3 were tagged with carboxyfluorescein succinimidyl ester (CFSE) and then were stimulated with lipopolysaccharides plus IL-21 or anti-IL-21 neutralizing antibody for 3 days. The proliferation of B cells was analyzed by flow cytometry. Anti-ANT antibodies in the supernatants were detected by ELISA. Results showed that IL-21R−/− mice developed significantly less inflammation of the myocardium than Balb/c mice. Numbers of the Tfh cells and levels of anti-ANT antibody were decreased in IL-21R−/− mice, indicating IL-21 signaling plays a role on the Tfh cell response. The percentage of CD19+CFSE+ B cells decreased in IL-21R−/− mice compared to VMC mice. And anti-ANT antibodies were detected at lower levels in cultured supernatant from IL-21R−/− mice than in those from VMC mice. These data suggest that IL-21R signal may contribute to anti-ANT antibody production and expansion of B cells in VMC mice.
Appendix
Available only for authorised users
Literature
1.
go back to reference Blauwet, L.A., and L.T. Cooper. 2010. Myocarditis. Progress in Cardiovascular Diseases 52: 274–288.CrossRefPubMed Blauwet, L.A., and L.T. Cooper. 2010. Myocarditis. Progress in Cardiovascular Diseases 52: 274–288.CrossRefPubMed
2.
go back to reference Fairweather, D., and N.R. Rose. 2007. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods 41: 118–122.CrossRefPubMedPubMedCentral Fairweather, D., and N.R. Rose. 2007. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods 41: 118–122.CrossRefPubMedPubMedCentral
3.
go back to reference Rangachari, M., N. Mauermann, R.R. Marty, S. Dirnhofer, M.O. Kurrer, V. Komnenovic, J.M. Penninger, and U. Eriksson. 2006. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. The Journal of Experimental Medicine 203: 2009–2019.CrossRefPubMedPubMedCentral Rangachari, M., N. Mauermann, R.R. Marty, S. Dirnhofer, M.O. Kurrer, V. Komnenovic, J.M. Penninger, and U. Eriksson. 2006. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. The Journal of Experimental Medicine 203: 2009–2019.CrossRefPubMedPubMedCentral
4.
go back to reference Valaperti, A., R.R. Marty, G. Kania, D. Germano, N. Mauermann, S. Dirnhofer, B. Leimenstoll, P. Blyszczuk, C. Dong, C. Mueller, L. Hunziker, and U. Eriksson. 2008. CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis. Journal of Immunology 180: 2686–2695.CrossRef Valaperti, A., R.R. Marty, G. Kania, D. Germano, N. Mauermann, S. Dirnhofer, B. Leimenstoll, P. Blyszczuk, C. Dong, C. Mueller, L. Hunziker, and U. Eriksson. 2008. CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis. Journal of Immunology 180: 2686–2695.CrossRef
5.
go back to reference Yang, F., W.F. Wu, Y.L. Yan, Y. Pang, Q. Kong, and Y.L. Huang. 2011. Expression of IL-23/Th17 pathway in a murine model of coxsackie virus B3-induced viral myocarditis. Virology Journal 8: 301.CrossRefPubMedPubMedCentral Yang, F., W.F. Wu, Y.L. Yan, Y. Pang, Q. Kong, and Y.L. Huang. 2011. Expression of IL-23/Th17 pathway in a murine model of coxsackie virus B3-induced viral myocarditis. Virology Journal 8: 301.CrossRefPubMedPubMedCentral
6.
go back to reference Fan, Y., W. Weifeng, Y. Yuluan, K. Qing, P. Yu, and H. Yanlan. 2011. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of coxsackievirus b3-induced viral myocarditis reduces myocardium inflammation. Virology Journal 8: 17.CrossRefPubMedPubMedCentral Fan, Y., W. Weifeng, Y. Yuluan, K. Qing, P. Yu, and H. Yanlan. 2011. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of coxsackievirus b3-induced viral myocarditis reduces myocardium inflammation. Virology Journal 8: 17.CrossRefPubMedPubMedCentral
7.
go back to reference Kong, Q., W. Wu, F. Yang, Y. Liu, Y. Xue, M. Gao, W. Lai, X. Pan, Y. Yan, Y. Pang, and Y. Deng. 2012. Increased expressions of IL-22 and Th22 cells in the coxsackievirus B3-induced mice acute viral myocarditis. Virology Journal 9: 232.CrossRefPubMedPubMedCentral Kong, Q., W. Wu, F. Yang, Y. Liu, Y. Xue, M. Gao, W. Lai, X. Pan, Y. Yan, Y. Pang, and Y. Deng. 2012. Increased expressions of IL-22 and Th22 cells in the coxsackievirus B3-induced mice acute viral myocarditis. Virology Journal 9: 232.CrossRefPubMedPubMedCentral
8.
go back to reference Vogelzang, A., H.M. McGuire, D. Yu, J. Sprent, C.R. Mackay, and C. King. 2008. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity 29: 127–137.CrossRefPubMed Vogelzang, A., H.M. McGuire, D. Yu, J. Sprent, C.R. Mackay, and C. King. 2008. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity 29: 127–137.CrossRefPubMed
9.
go back to reference King, C., S.G. Tangye, and C.R. Mackay. 2008. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annual Review of Immunology 26: 741–766.CrossRefPubMed King, C., S.G. Tangye, and C.R. Mackay. 2008. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annual Review of Immunology 26: 741–766.CrossRefPubMed
10.
go back to reference Bubier, J.A., T.J. Sproule, O. Foreman, R. Spolski, D.J. Shaffer, H.C. Morse 3rd, W.J. Leonard, and D.C. Roopenian. 2009. A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice. Proceedings of the National Academy of Sciences of the United States of America 106: 1518–1523.CrossRefPubMedPubMedCentral Bubier, J.A., T.J. Sproule, O. Foreman, R. Spolski, D.J. Shaffer, H.C. Morse 3rd, W.J. Leonard, and D.C. Roopenian. 2009. A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice. Proceedings of the National Academy of Sciences of the United States of America 106: 1518–1523.CrossRefPubMedPubMedCentral
11.
go back to reference Sutherland, A.P., T. Van Belle, A.L. Wurster, A. Suto, M. Michaud, D. Zhang, M.J. Grusby, and M. von Herrath. 2009. Interleukin-21 is required for the development of type 1 diabetes in NOD mice. Diabetes 58: 1144–1155.CrossRefPubMedPubMedCentral Sutherland, A.P., T. Van Belle, A.L. Wurster, A. Suto, M. Michaud, D. Zhang, M.J. Grusby, and M. von Herrath. 2009. Interleukin-21 is required for the development of type 1 diabetes in NOD mice. Diabetes 58: 1144–1155.CrossRefPubMedPubMedCentral
12.
go back to reference Young, D.A., M. Hegen, H.L. Ma, M.J. Whitters, L.M. Albert, L. Lowe, M. Senices, P.W. Wu, B. Sibley, Y. Leathurby, T.P. Brown, C. Nickerson-Nutter, J.C. Keith Jr., and M. Collins. 2007. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis and Rheumatism 56: 1152–1163.CrossRefPubMed Young, D.A., M. Hegen, H.L. Ma, M.J. Whitters, L.M. Albert, L. Lowe, M. Senices, P.W. Wu, B. Sibley, Y. Leathurby, T.P. Brown, C. Nickerson-Nutter, J.C. Keith Jr., and M. Collins. 2007. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis and Rheumatism 56: 1152–1163.CrossRefPubMed
13.
go back to reference Yang, F., W.H. Mo, B.P. Tan, X.M. Wei, and H. Wang. 2015. Increased frequency of follicular helper T cells in mice viral myocarditis is relevant with anti-ANT antoantibody. Virology Journal 12: 20.CrossRefPubMedPubMedCentral Yang, F., W.H. Mo, B.P. Tan, X.M. Wei, and H. Wang. 2015. Increased frequency of follicular helper T cells in mice viral myocarditis is relevant with anti-ANT antoantibody. Virology Journal 12: 20.CrossRefPubMedPubMedCentral
14.
go back to reference Stritesky, G.L., N. Yeh, and M.H. Kaplan. 2008. IL-23 promotes maintenance but not commitment to the Th17 lineage. Journal of Immunology 181: 5948–5955.CrossRef Stritesky, G.L., N. Yeh, and M.H. Kaplan. 2008. IL-23 promotes maintenance but not commitment to the Th17 lineage. Journal of Immunology 181: 5948–5955.CrossRef
15.
go back to reference Parrish-Novak, J., S.R. Dillon, A. Nelson, A. Hammond, C. Sprecher, J.A. Gross, J. Johnston, K. Madden, W. Xu, J. West, S. Schrader, S. Burkhead, M. Heipel, C. Brandt, J.L. Kuijper, J. Kramer, D. Conklin, S.R. Presnell, J. Berry, F. Shiota, S. Bort, K. Hambly, S. Mudri, C. Clegg, M. Moore, F.J. Grant, C. Lofton-Day, T. Gilbert, F. Rayond, A. Ching, L. Yao, D. Smith, P. Webster, T. Whitmore, M. Maurer, K. Kaushansky, R.D. Holly, and D. Foster. 2000. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408: 57–63.CrossRefPubMed Parrish-Novak, J., S.R. Dillon, A. Nelson, A. Hammond, C. Sprecher, J.A. Gross, J. Johnston, K. Madden, W. Xu, J. West, S. Schrader, S. Burkhead, M. Heipel, C. Brandt, J.L. Kuijper, J. Kramer, D. Conklin, S.R. Presnell, J. Berry, F. Shiota, S. Bort, K. Hambly, S. Mudri, C. Clegg, M. Moore, F.J. Grant, C. Lofton-Day, T. Gilbert, F. Rayond, A. Ching, L. Yao, D. Smith, P. Webster, T. Whitmore, M. Maurer, K. Kaushansky, R.D. Holly, and D. Foster. 2000. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408: 57–63.CrossRefPubMed
16.
go back to reference Steele, N., A. Anthony, M. Saunders, B. Esmarck, E. Ehrnrooth, P.E. Kristjansen, A. Nihlén, L.T. Hansen, and J. Cassidy. 2012. A phase 1 trial of recombinant human IL-21 in combination with cetuximab in patients with metastatic colorectal cancer. British Journal of Cancer 106: 793–798.CrossRefPubMedPubMedCentral Steele, N., A. Anthony, M. Saunders, B. Esmarck, E. Ehrnrooth, P.E. Kristjansen, A. Nihlén, L.T. Hansen, and J. Cassidy. 2012. A phase 1 trial of recombinant human IL-21 in combination with cetuximab in patients with metastatic colorectal cancer. British Journal of Cancer 106: 793–798.CrossRefPubMedPubMedCentral
17.
go back to reference Shekhar, S., and X. Yang. 2012. The darker side of follicular helper T-cells: from autoimmunity to immunodeficiency. Cellular & Molecular Immunology 9: 380–385.CrossRef Shekhar, S., and X. Yang. 2012. The darker side of follicular helper T-cells: from autoimmunity to immunodeficiency. Cellular & Molecular Immunology 9: 380–385.CrossRef
18.
go back to reference Romme Christensen, J., L. Bornsen, R. Ratzer, F. Piehl, M. Khademi, T. Olsson, P.S. Sorensen, and F. Sellebjerg. 2013. Systemic inflammation in progressive multiple sclerosis involves follicular TH, TH17, and activated B-cells and correlates with progression. PloS One 8: e57820.CrossRefPubMed Romme Christensen, J., L. Bornsen, R. Ratzer, F. Piehl, M. Khademi, T. Olsson, P.S. Sorensen, and F. Sellebjerg. 2013. Systemic inflammation in progressive multiple sclerosis involves follicular TH, TH17, and activated B-cells and correlates with progression. PloS One 8: e57820.CrossRefPubMed
19.
go back to reference Korn, T., E. Bettelli, W. Gao, A. Awasthi, A. Jäger, T.B. Strom, M. Oukka, and V.K. Kuchroo. 2007. IL-21 initiates an alternative pathway to induce pro-inflammatory TH17 cells. Nature 448: 484–487.CrossRefPubMedPubMedCentral Korn, T., E. Bettelli, W. Gao, A. Awasthi, A. Jäger, T.B. Strom, M. Oukka, and V.K. Kuchroo. 2007. IL-21 initiates an alternative pathway to induce pro-inflammatory TH17 cells. Nature 448: 484–487.CrossRefPubMedPubMedCentral
20.
go back to reference Spolski, R., and W.J. Leonard. 2008. IL-21: basic biology and implications for cancer and autoimmunity. Annual Review of Immunology 26: 57–79.CrossRefPubMed Spolski, R., and W.J. Leonard. 2008. IL-21: basic biology and implications for cancer and autoimmunity. Annual Review of Immunology 26: 57–79.CrossRefPubMed
21.
go back to reference Wang, Y., G. Li, J.X. Tang, and H. Chang. 2012. Time course of interleukin-21 and related cytokines expression in rats with experimental autoimmune myocarditis. Zhonghua Xin Xue Guan Bing Za Zhi 40: 43–49.PubMed Wang, Y., G. Li, J.X. Tang, and H. Chang. 2012. Time course of interleukin-21 and related cytokines expression in rats with experimental autoimmune myocarditis. Zhonghua Xin Xue Guan Bing Za Zhi 40: 43–49.PubMed
Metadata
Title
A Critical Role for IL-21 Receptor Signaling in the Coxsackievirus B3-Induced Myocarditis
Authors
Fan Yang
Xiao-mou Wei
Wen-wu Liang
Wen-hong Mo
Bao-ping Tan
Hong Wang
Publication date
01-08-2017
Publisher
Springer US
Published in
Inflammation / Issue 4/2017
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-017-0586-5

Other articles of this Issue 4/2017

Inflammation 4/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.